BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Capital expenditures 2016–2023
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$18,000FY2023 · since FY2016: $103,000 → $18,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $18,000 | -37.9% |
| FY2022 | $29,000 | -91.2% |
| FY2021 | $330,000 | -12.7% |
| FY2020 | $378,000 | -20.1% |
| FY2019 | $473,000 | +28.2% |
| FY2018 | $369,000 | +105.0% |
| FY2017 | $180,000 | +74.8% |
| FY2016 | $103,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice